Home » Newsletters » BioWorld Science

BioWorld Science

May 27, 2011

View Archived Issues

LIPN gene mutation correlates with late-onset autosomal recessive ichthyosis

HRA Pharma and ASKA Pharmaceutical enter licensing agreement in Japan for ellaOne

Novel phosphodiesterase 10A inhibitors designed

New sponge-derived anticancer polyketides described

Daiichi Sankyo presents novel erythropoietin production enhancers

InterMune provides update on development and commercialization of Esbriet

Oncothyreon begins phase II portion of phase I/II trial of PX-866 with cetuximab

Initiation of phase II study triggers milestone payment from Bristol-Myers Squibb to AMRI

Preclinical data support further development of PF-4348235 for treatment of COPD

Findings disclosed from two phase II trials of NXL-104/ceftazidime

Nexvax-2 vaccine is safe and bioactive in phase I trial in celiac disease

Centella Therapeutics gains exclusive rights to antitumor agent CEN-209

FDA approves IND for phase I trial of PWT-33597

Aastrom and CPC Clinical Research enter agreement for phase III REVIVE program of ixmyelocel-T

FLAME study shows enhanced stroke recovery with fluoxetine

Dynavax completes 12-month follow-up in phase III Heplisav trial

Active Biotech's ABR-215757 improves SLE symptoms in exploratory phase II trial

GSK presents new bromodomain inhibitors

Phase II extension data encouraging for Derma Sciences' DSC-127 in diabetes-related foot ulcers

EV-71 vaccine against hand, foot and mouth disease shows promise in phase I trial

Futurechem presents new beta-amyloid production inhibitors

Lytix Biopharma completes two phase I/IIa trials of topical antimicrobial drug Lytixar

NHLBI stops AIM-HIGH study of niacin added to simvastatin early

Ellavie spray approved in Sweden to treat symptoms of menopause

Zeria presents data showing efficacy of Acofide in treatment of functional dyspepsia

German authorities approve Sativex for treatment of spasticity due to MS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...